BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17144902)

  • 1. Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease.
    Avramovich-Tirosh Y; Amit T; Bar-Am O; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2007 Jan; 100(2):490-502. PubMed ID: 17144902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
    Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
    J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo-APP translation and processing.
    Yogev-Falach M; Bar-Am O; Amit T; Weinreb O; Youdim MB
    FASEB J; 2006 Oct; 20(12):2177-9. PubMed ID: 16935943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG.
    Avramovich-Tirosh Y; Reznichenko L; Mit T; Zheng H; Fridkin M; Weinreb O; Mandel S; Youdim MB
    Curr Alzheimer Res; 2007 Sep; 4(4):403-11. PubMed ID: 17908043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.
    Gal S; Zheng H; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):79-88. PubMed ID: 16181414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.
    Mandel S; Amit T; Bar-Am O; Youdim MB
    Prog Neurobiol; 2007 Aug; 82(6):348-60. PubMed ID: 17659826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
    Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
    Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
    Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
    J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
    Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
    J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.
    Youdim MB; Amit T; Bar-Am O; Weinreb O; Yogev-Falach M
    Neurotox Res; 2006 Dec; 10(3-4):181-92. PubMed ID: 17197368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives.
    Mandel S; Weinreb O; Amit T; Youdim MB
    Brain Res Brain Res Rev; 2005 Apr; 48(2):379-87. PubMed ID: 15850677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin-1 protects against neurotoxicities induced by Swedish amyloid precursor protein via the ErbB4 receptor.
    Woo RS; Lee JH; Kim HS; Baek CH; Song DY; Suh YH; Baik TK
    Neuroscience; 2012 Jan; 202():413-23. PubMed ID: 22186019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine.
    Bar-Am O; Weinreb O; Amit T; Youdim MB
    FASEB J; 2005 Nov; 19(13):1899-901. PubMed ID: 16148027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fermented papaya preparation attenuates beta-amyloid precursor protein: beta-amyloid-mediated copper neurotoxicity in beta-amyloid precursor protein and beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells.
    Zhang J; Mori A; Chen Q; Zhao B
    Neuroscience; 2006 Nov; 143(1):63-72. PubMed ID: 16962711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation.
    Bar-Am O; Amit T; Weinreb O; Youdim MB; Mandel S
    J Alzheimers Dis; 2010; 21(2):361-71. PubMed ID: 20555137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells.
    Zhang JJ; Zhang RF; Meng XK
    Neurosci Lett; 2009 Oct; 464(3):165-9. PubMed ID: 19699263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of isatin on cell cycle arrest and apoptosis of neuroblastoma cell line SH-SY5Y].
    Song JL; Yue W; Hou L; Ge YL
    Ai Zheng; 2008 Mar; 27(3):283-8. PubMed ID: 18334118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirubin-3'-monoxime inhibits beta-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells.
    Zhang S; Zhang Y; Xu L; Lin X; Lu J; Di Q; Shi J; Xu J
    Neurosci Lett; 2009 Jan; 450(2):142-6. PubMed ID: 19027827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.